BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 16531723)

  • 41. Transdermal opioids for cancer pain.
    Skaer TL
    Health Qual Life Outcomes; 2006 Mar; 4():24. PubMed ID: 16573839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A pitfall to avoid when starting a patient on transdermal fentanyl.
    Low JA; Chye R
    Aust Fam Physician; 2000 Dec; 29(12):1173-5. PubMed ID: 11140227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transdermal buprenorphine in cancer pain and palliative care.
    Sittl R
    Palliat Med; 2006; 20 Suppl 1():s25-30. PubMed ID: 16764218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Switching from transdermal drugs: an observational "N of 1" study of fentanyl and buprenorphine.
    Mercadante S; Porzio G; Fulfaro F; Aielli F; Verna L; Ficorella C; Casuccio A; Riina S; Intravaia G; Mangione S
    J Pain Symptom Manage; 2007 Nov; 34(5):532-8. PubMed ID: 17629666
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Home terminal care for lung cancer--subcutaneous injection with morphine hydrochloride for cancer related pain from metastatic bone cancer in a terminal lung cancer patient].
    Nomura Y; Abe M; Kano S; Hachisuka H
    Gan To Kagaku Ryoho; 1996 Dec; 23 Suppl 3():285-7. PubMed ID: 8982317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fentanyl patch sufficient analgesia for only one day.
    Sasson M; Shvartzman P
    J Pain Symptom Manage; 2006 May; 31(5):389-91. PubMed ID: 16716868
    [No Abstract]   [Full Text] [Related]  

  • 47. Breakthrough strong opioid analgesia prescription in patients using transdermal fentanyl admitted to a hospice.
    Lawrie I; Lloyd-Williams M; Waterhouse E
    Am J Hosp Palliat Care; 2003; 20(3):229-30. PubMed ID: 12785045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How should we use transdermal fentanyl (TF) for pain management in palliative care patients?
    Fainsinger RL; Bruera E
    J Palliat Care; 1996; 12(1):48-53. PubMed ID: 8857249
    [No Abstract]   [Full Text] [Related]  

  • 49. Three-cycle fentanyl patch system contributes to stable control of plasma fentanyl concentration in gynecologic cancer pain patients.
    Kanamori C; Kanamori T; Tanaka Y; Kanzaki H
    Taiwan J Obstet Gynecol; 2011 Mar; 50(1):79-84. PubMed ID: 21482380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of transdermal fentanyl on quality of life in rheumatoid arthritis.
    Berliner MN; Giesecke T; Bornhövd KD
    Clin J Pain; 2007; 23(6):530-4. PubMed ID: 17575494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of local administration of transdermal fentanyl on peripheral opioid analgesia.
    Worrich S; Schuler G; Janicki PK
    Pain Med; 2007; 8(1):41-7. PubMed ID: 17244103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Home therapy approach in cancer patients--pain control (case 3-1)].
    Matsumoto S
    Gan To Kagaku Ryoho; 1994 Dec; 21 Suppl 4():565-7; discussion 568. PubMed ID: 7528493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Utilisation pattern of fentanyl transdermal system in The Netherlands.
    Breekveldt-Postma NS; Penning-van Beest FJ; Herings RM
    Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):129-34. PubMed ID: 15386723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fentanyl transdermal absorption linked to pharmacokinetic characteristics in patients undergoing palliative care.
    Van Nimmen NF; Poels KL; Menten JJ; Godderis L; Veulemans HA
    J Clin Pharmacol; 2010 Jun; 50(6):667-78. PubMed ID: 20097932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transdermal fentanyl reduces pain and improves functional activity in neuropathic pain states.
    Agarwal S; Polydefkis M; Block B; Haythornthwaite J; Raja SN
    Pain Med; 2007; 8(7):554-62. PubMed ID: 17883740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prolonged central intravenous ketorolac continuous infusion in a cancer patient with intractable bone pain.
    Gordon RL
    Ann Pharmacother; 1998 Feb; 32(2):193-6. PubMed ID: 9496404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fentanyl effervescent buccal tablets: new formulation. For cancer patients with breakthrough pain: a second buccal formulation with minimal evaluation.
    Prescrire Int; 2009 Oct; 18(103):205. PubMed ID: 19882786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of transdermal fentanyl treatment on serum cortisol concentrations in patients with non-cancer pain.
    Ozyuvaci E; Yanmaz Alnigenis N; Altan A
    J Pain Symptom Manage; 2004 Sep; 28(3):277-81. PubMed ID: 15336341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opioids for metastatic bone pain.
    Hara S
    Oncology; 2008; 74 Suppl 1():52-4. PubMed ID: 18758198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An alternative algorithm for dosing transdermal fentanyl for cancer-related pain.
    Breitbart W; Chandler S; Eagel B; Ellison N; Enck RE; Lefkowitz M; Payne R
    Oncology (Williston Park); 2000 May; 14(5):695-705; discussion 705, 709-17. PubMed ID: 10853461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.